Is the expectation for retention samples for bulk drug product, for further packaging, not in the final package, the same as for APIs in Q7A? 1.23K viewsOctober 10, 2022DrugsPharmaceutical 0 Sam Smith11.38K October 2, 2020 0 Comments Spread the loveSpread the love 1 Answer ActiveVotedNewestOldest 0 Blogolu28.38K Posted October 2, 2020 0 Comments Spread the loveNo. Q7A pertains only to APIs. Bulk drug tablets or capsules for further packaging are covered by 21 CFR 211. Spread the love You are viewing 1 out of 1 answers, click here to view all answers. Login
